Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

[This corrects the article DOI: 10.1002/fsn3.4335.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12400365PMC
http://dx.doi.org/10.1002/fsn3.70679DOI Listing

Publication Analysis

Top Keywords

correction "the
4
"the therapeutic
4
therapeutic potential
4
potential red
4
red beetroot
4
beetroot intake
4
intake muscle
4
muscle atrophy
4
atrophy immobilized
4
immobilized mouse
4

Similar Publications

Phase I dose escalation trials in oncology generally aim to find the maximum tolerated dose. However, with the advent of molecular-targeted therapies and antibody drug conjugates, dose-limiting toxicities are less frequently observed, giving rise to the concept of optimal biological dose (OBD), which considers both efficacy and toxicity. The estimand framework presented in the addendum of the ICH E9(R1) guidelines strengthens the dialogue between different stakeholders by bringing in greater clarity in the clinical trial objectives and by providing alignment between the targeted estimand under consideration and the statistical analysis methods.

View Article and Find Full Text PDF

Evidence-based practices (EBPs) are most effective when they are delivered with a high degree of fidelity, or as they are intended to be delivered. Because clinicians often deviate from fidelity, it is important to monitor EBP fidelity over time to guide corrective actions. However, little is known about current fidelity monitoring practices in community behavioral health care.

View Article and Find Full Text PDF